# Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

> **NCT02911935** · PHASE2,PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 200 (actual)

## Conditions studied

- Respiratory Syncytial Virus, Bronchiolitis

## Interventions

- **DRUG:** Oral azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02911935
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911935, "Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02911935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*